Xu X - Search Results

1

Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells.

Xu X, Liu Y, Su J, Li D, Hu J, Huang Q, Lu M, Liu X, Ren J, Chen W, Sun L. Xu X, et al. Oncol Rep. 2016 Feb;35(2):923-31. doi: 10.3892/or.2015.4414. Epub 2015 Nov 12. Oncol Rep. 2016. PMID: 26573774

2

[Effect of GSH combined with chemotherapy on the activities of serum superoxide dismutase and lipid peroxidation among cancer patients].

Xu XH, Fu XY, Yi F, DU JT, Xue F, Huang Q, Li DJ, Wang YL. Xu XH, et al. Zhonghua Gan Zang Bing Za Zhi. 2008 Nov;16(11):861-2. Zhonghua Gan Zang Bing Za Zhi. 2008. PMID: 19032874 Chinese. No abstract available.

3

Erlotinib in advanced non-small-cell lung cancer after gefitinib failure.

Zhou ZT, Xu XH, Wei Q, Lu MQ, Wang J, Wen CH. Zhou ZT, et al. Cancer Chemother Pharmacol. 2009 Nov;64(6):1123-7. doi: 10.1007/s00280-009-0973-1. Epub 2009 Mar 26. Cancer Chemother Pharmacol. 2009. PMID: 19322567 Clinical Trial.

4

[Effects of celecoxib on the proliferation and apoptosis of human nasopharyngeal carcinoma cell line CNE-2].

Xu X, Yi F, Fu X, Li D, Huang Q, Du J. Xu X, et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Aug;23(15):682-5. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009. PMID: 19947251 Chinese.

5

Clinical effect of erlotinib as first-line treatment for Asian elderly patients with advanced non-small-cell lung cancer.

Xu XH, Su J, Fu XY, Xue F, Huang Q, Li DJ, Lu MQ. Xu XH, et al. Cancer Chemother Pharmacol. 2011 Feb;67(2):475-9. doi: 10.1007/s00280-010-1450-6. Epub 2010 Sep 16. Cancer Chemother Pharmacol. 2011. PMID: 20844881 Clinical Trial.

6

Identification of cancer stem-like CD44+ cells in human nasopharyngeal carcinoma cell line.

Su J, Xu XH, Huang Q, Lu MQ, Li DJ, Xue F, Yi F, Ren JH, Wu YP. Su J, et al. Arch Med Res. 2011 Jan;42(1):15-21. doi: 10.1016/j.arcmed.2011.01.007. Arch Med Res. 2011. PMID: 21376257

7

Study of the correlationship link between microRNAs and nasopharyngeal carcinoma.

Xu XH, Liu Y. Xu XH, et al. Saudi Med J. 2014 Apr;35(4):329-35. Saudi Med J. 2014. PMID: 24749128

8

ShRNA targeting Bmi-1 sensitizes CD44⁺ nasopharyngeal cancer stem-like cells to radiotherapy.

Xu XH, Liu XY, Su J, Li DJ, Huang Q, Lu MQ, Yi F, Ren JH, Chen WH. Xu XH, et al. Oncol Rep. 2014 Aug;32(2):764-70. doi: 10.3892/or.2014.3267. Epub 2014 Jun 13. Oncol Rep. 2014. PMID: 24927072

9

Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells.

Xu XH, Liu Y, Li DJ, Hu J, Su J, Huang Q, Lu MQ, Yi F, Bao D, Fu YZ. Xu XH, et al. Technol Cancer Res Treat. 2016 Oct;15(5):NP27-39. doi: 10.1177/1533034615599461. Epub 2015 Aug 20. Technol Cancer Res Treat. 2016. PMID: 26294655 Free article.

10

[Effect of gene silencing of Bmi-1 on proliferation regulation of CD44+ nasopharyngeal carcinoma cancer stem-like cells].

Xu X, Liu Y, Li D, Su J, Hu J, Lu M, Yi F, Reng J, Chen W. Xu X, et al. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 May;29(10):941-7. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015. PMID: 26596015 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58,201 results

Search Page

Filters